News

Researchers at the Max Planck Institute develop a new pharmacological approach that specifically targets receptor interactions – with implications for immune defense and blood pressure regulation more

NTSR2 agonists open up new avenues for the treatment of heart failure
  more

Declining NAD⁺ levels in the aging heart weaken circadian rhythm and cardiac health more

Renowned scientists, including Didier Stainier from the Max Planck Institute for Heart and Lung Research in Bad Nauheim, argue in the journal Genetics for a paradigm shift in the field of genetics. In their view, classical Mendelian genetics is not sufficient to explain complex gene effects in interaction with the environment and genetic background. more

Membrane protein PEAR1 prevents the development of metastases
  more

Transcription factor TAF4A preserves nuclei in muscle stem cells and initiates muscle regeneration after injury
  more

GPR153 promotes inflammatory reactions in the vessel wall in response to acute damage more